CFR

The Harrington Scholar-Innovator Award recognizes outstanding physician-scientists whose work has potential to advance standard of care. Each year up to 12 Harrington Scholar-Innovators are chosen.

The award selection committee seeks breakthrough discoveries defined by innovation, creativity and potential for clinical impact, including:
Discoveries deemed to address unmet medical needs
Modulators of novel targets
Potential to be developed into a commercial program
Strong intellectual property (IP) or protection strategy
May be a small molecule, biologic, or other therapeutic modality
Diagnostics or devices only acceptable as part of a therapeutic development project
The two-year grant includes:
$100,000 guaranteed, opportunity to qualify for up to $1,100,000
Drug development expertise and project management support
A personalized team of drug developers and project manager for each award recipient
Expert business, commercialization and clinical development advice
Regulatory assistance
Intellectual property (IP) review and advice
Assistance identifying and securing additional financial support based on project needs
To be eligible, the applicant must hold a MD or MD/PhD (or equivalent), faculty position at an accredited academic medical center, university or research institution in the US or Canada, and conduct the majority of his/her/their research at that institution. A project must have a single Principal Investigator (PI), who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.
Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.

Learn More